AMPICILLIN
Approved
Approval ID
3f6275f9-ee6f-4087-b672-5611d6870558
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Oct 18, 2023
Manufacturers
FDA
Methapharm Inc.
DUNS: 066672887
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Ampicillin Injection
PRODUCT DETAILS
NDC Product Code67850-021
Application NumberANDA090354
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMarch 13, 2019
Generic NameAmpicillin Injection
INGREDIENTS (1)
AMPICILLIN SODIUMActive
Quantity: 1 g in 1 g
Code: JFN36L5S8K
Classification: ACTIM
Ampicillin Injection
PRODUCT DETAILS
NDC Product Code67850-023
Application NumberANDA090354
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMarch 13, 2019
Generic NameAmpicillin Injection
INGREDIENTS (1)
AMPICILLIN SODIUMActive
Quantity: 250 mg in 250 mg
Code: JFN36L5S8K
Classification: ACTIM
Ampicillin Injection
PRODUCT DETAILS
NDC Product Code67850-022
Application NumberANDA090354
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMarch 13, 2019
Generic NameAmpicillin Injection
INGREDIENTS (1)
AMPICILLIN SODIUMActive
Quantity: 2 g in 2 g
Code: JFN36L5S8K
Classification: ACTIM
Ampicillin Injection
PRODUCT DETAILS
NDC Product Code67850-024
Application NumberANDA090354
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMarch 13, 2019
Generic NameAmpicillin Injection
INGREDIENTS (1)
AMPICILLIN SODIUMActive
Quantity: 500 mg in 500 mg
Code: JFN36L5S8K
Classification: ACTIM